Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
- Resource Type
- Article
- Authors
- Gao, Yan; He, Haixia; Li, Xueping; Zhang, Liling; Xu, Wei; Feng, Ru; Li, Wenyu; Xiao, Yin; Liu, Xinxiu; Chen, Yu; Wang, Xiaoxiao; Bai, Bing; Wu, Huijing; Cai, Qingqing; Li, Zhiming; Li, Jibin; Lin, Suxia; He, Yanxia; Ping, Liqin; Huang, Cheng
- Source
- Signal Transduction & Targeted Therapy; 5/17/2024, p1-9, 9p
- Subject
- Language
- ISSN
- 20959907